Neurolief

About:

Neurolief is pioneering brain neuromodulation and digital therapeutics technology to treat depression and other neurological disorders.

Website: http://www.neurolief.com/

Top Investors: Terra Venture Partners, KT Squared, Sawai

Description:

Neurolief is a neuromodulation company dedicated to bringing relief to patients suffering from mental health and neurological disorders. The company consists of highly experienced professionals with a proven track record in neuroscience, neuromodulation technology, and the neurotech industry. Neurolief has developed a disruptive platform technology, the world's first and only non-invasive, multi-channel brain neuromodulation system designed to concurrently neuromodulate major neural pathways in the head and thereby affect brain regions involved in the control and modulation of mood and pain.

Total Funding Amount:

$20M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Netanya, HaMerkaz, Israel

Founded Date:

2013-11-30

Contact Email:

amit.dar(AT)neurolief.com

Founders:

Amit Dar

Number of Employees:

11-50

Last Funding Date:

2023-12-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai